DUBLIN, Sept 19, 2018 /PRNewswire/ --
The "Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global rapid microbiology testing market is expected to USD 5.09 billion by 2023 from USD 3.45 billion in 2018, growing at a CAGR of 8.1%.
Growth in the rapid microbiology testing market can be attributed to factors such as the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; increased funding, research grants, and public-private investments; and increasing awareness about rapid microbiology testing.
This report broadly segments the rapid microbiology testing market into products, methods, applications, end users, and regions.
Based on product, the global rapid microbiology testing market is segmented into instruments, reagents & kits, and consumables. In 2018, the instruments segment is expected to account for the largest share of the market owing to factors such as the significant adoption of modern laboratory instruments in the research and academic sectors (coupled with growing industry-academia collaborations for genomic research) and the ongoing trend of laboratory automation among clinical laboratories.
Based on method, the global rapid microbiology testing market is divided into five segments growth-based, viability-based, cellular component-based, nucleic acid-based, and other testing methods. The growth-based rapid microbiology testing segment is expected to account for the largest share of the market in 2018. The large share of this segment can be attributed to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations.
On the basis of application, the rapid microbiology testing market is segmented into clinical disease diagnosis, food & beverage testing, pharmaceutical & biological drug testing, cosmetics and personal care products testing, environmental applications, research applications, and other applications. The clinical disease diagnosis application segment is expected to dominate the rapid microbiology testing market during the forecast period. This can primarily be attributed to the increasing use of rapid microbiology testing for the diagnosis of infectious diseases in humans; rising emphasis on effective and early disease diagnosis across major markets; and the introduction of advanced, accurate, and rapid methods for faster clinical diagnosis.
The rapid microbiology testing market, by end user, is segmented into diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical companies, CROs, and other end users. In 2018, the diagnostic laboratories & hospitals segment is expected to account for the largest share of the rapid microbiology testing market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure, and technological advancements in rapid microbial testing.
North America is expected to dominate the global rapid microbiology testing market in 2018. Technological advancements in the field of rapid microbial testing, the rising incidence of infectious diseases, and growing food safety concerns are driving the growth of the rapid microbiology testing market in North America. Additionally, easy accessibility and high adoption of advanced diagnostic technologies owing to the significant per capita annual healthcare expenditure by the US and Canadian governments are increasing the adoption of rapid microbiology testing in this region. The Asia Pacific region is expected to grow at the highest CAGR due to the increasing healthcare expenditure and growing initiatives to promote the use of advanced rapid microbiology testing technologies in Asia Pacific countries.
However, reimbursement concerns and the high cost of rapid microbiology testing products are the major factors restricting market growth.
As of 2017, some of the major players operating in this market include bioMrieux SA (France), Abbott Laboratories Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Rapid Microbiology Testing Market Overview
4.2 Regional Analysis: Rapid Microbiology Testing Market, By Product
4.3 Rapid Microbiology Testing Reagents Market, By Type
4.4 Asia Pacific: Rapid Microbiology Testing Market, By Method, 2018
4.5 Rapid Microbiology Testing Market, By Application
4.6 Regional Analysis: Rapid Microbiology Testing Market, By End User
4.7 Rapid Microbiology Testing Market, By Country
5 Market Overview
5.2 Market Dynamics
126.96.36.199 Rising Incidence of Infectious Diseases
188.8.131.52 Technological Advancements
184.108.40.206 Increasing Food Safety Concerns
220.127.116.11 Funding, Research Grants, and Public-Private Investments
18.104.22.168 Unfavorable Reimbursement Policies
22.214.171.124 Government Initiatives for the Detection of Antimicrobial Resistance
126.96.36.199 Emerging Countries
188.8.131.52 Bioterrorism Surveillance
184.108.40.206 High Cost of Rapid Microbiology Testing Instruments
5.2.5 Burning Issues
220.127.116.11 Bundled Sales By Market Giants
18.104.22.168 Stringent Policies and Expected Regulatory Changes
6 Rapid Microbiology Testing Market, By Method
6.2 Growth-Based Rapid Microbiology Testing
6.3 Cellular Component-Based Rapid Microbiology Testing
6.4 Nucleic Acid-Based Rapid Microbiology Testing
6.5 Viability-Based Rapid Microbiology Testing
6.6 Other Rapid Microbiology Testing Methods
7 Rapid Microbiology Testing Market, By Product
7.2.1 Automated Microbial Identification and Antimicrobial Susceptibility Testing Systems
7.2.2 Mass Spectrometers
7.2.3 Pcr Systems
7.2.4 Bioluminescence- and Fluorescence-Based Detection Systems
7.2.6 Active Air Samplers
7.2.7 Other Instruments
7.3 Reagents & Kits
7.3.1 Sterility Testing Reagents & Kits
7.3.2 Other Reagents & Kits
8 Rapid Microbiology Testing Market, By Application
8.2 Clinical Disease Diagnosis
8.3 Food & Beverage Testing
8.4 Pharmaceutical & Biological Drug Testing
8.5 Environmental Testing
8.6 Cosmetics & Personal Care Products Testing
8.7 Research Applications
8.8 Other Applications
9 Rapid Microbiology Testing Market, By End User
9.2 Diagnostic Laboratories & Hospitals
9.3 Food & Beverage Companies
9.4 Pharmaceutical & Biotechnology Companies
9.5 Contract Research Organizations
9.6 Other End Users
10 Rapid Microbiology Testing Market, By Region
10.2 North America
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific
10.4.4 Rest of Asia Pacific (RoAPAC)
10.5 Rest of the World
11 Competitive Landscape
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Product Launches, Approvals, and Enhancements
11.3.3 Collaborations and Agreements
12 Company Profiles
12.1 Abbott Laboratories
12.2 Becton, Dickinson and Company
12.4 Bruker Corporation
12.5 Charles River Laboratories International, Inc.
12.6 Danaher Corporation
12.7 Don Whitley Scientific Limited
12.8 Merck KGaA
12.9 Neogen Corporation
12.10 Quidel Corporation
12.11 Rapid Micro Biosystems, Inc.
12.12 Sartorius Group
12.13 Thermo Fisher Scientific
12.14 TSI, Inc.
12.15 Vivione Biosciences, LLC
For more information about this report visit
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets